Stocktoria

Akso Health Group AHG

Nasdaq · stock · Services-Business Services, NEC · website · IPO 2017-11-03

Akso Health Group statistics & valuation

Market cap$1.1B
P / S83.0×
P / B6.3×
Net margin-135.0%
Return on equity-10.3%
FCF margin-92.5%
Return on capital-11.4%
Graham number -90.7%$0.14

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($0.14); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
29.00% 53.10% 6.70% -1023.10% -1964.80% -267.00% -10.30% -391.80% -913.40% -135.00% 2017201820192020202120222023202420252026
Gross margin (%)
77.40% 87.00% 99.40% 99.00% 9.60% 9.60% 5.10% -1.90% -0.10% 2017201820192020202120222023202420252026
Operating margin (%)
33.50% 61.50% -8.70% -691.20% -239.30% -51.70% -108.20% -357.80% -1125.40% -149.70% 2017201820192020202120222023202420252026
Return on equity (%)
36.50% 46.70% 4.40% -148.00% -201.60% -137.20% -15.40% -6.80% -67.80% -10.30% 2017201820192020202120222023202420252026
Shares outstanding
42.9M 48.0M 52.9M 48.8M 48.9M 68.6M 68.6M 437.2M 1.66B 2.17B 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
30.20% 40.00% 3.20% -88.50% -109.90% -26.80% -6.60% -6.70% -62.80% -9.80% 2017201820192020202120222023202420252026
Free cash flow margin (%)
6.90% -92.50% 2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
$0.20 $1.37 $0.10 -$1.46 -$0.71 -$0.28 -$0.02 $0.07 $0.16 $0.01 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Akso Health Group trades at about 146.9× earnings — above its 10-year norm (10-year range 8.5×–219×, median 25.1×).

8.5× 219×

Shaded band = 10-year range (8.5×–219×); dot = today's 146.9×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin-0.1%-1.9%5.1%9.6%9.6%99.0%99.4%—87.0%77.4%
Operating margin-149.7%-1125.4%-357.8%-108.2%-51.7%-239.3%-691.2%-8.7%61.5%33.5%
Net margin-135.0%-913.4%-391.8%-10.3%-267.0%-1964.8%-1023.1%6.7%53.1%29.0%
FCF margin-92.5%6.9%————————
Return on assets-9.8%-62.8%-6.7%-6.6%-26.8%-109.9%-88.5%3.2%40.0%30.2%
Return on equity-10.3%-67.8%-6.8%-15.4%-137.2%-201.6%-148.0%4.4%46.7%36.5%
Current ratio21.7714.2039.521.761.242.094.213.686.84—

Computed from company filings · US · as of 2025-03-31. Facts plus Stocktoria's own computed scores — not investment advice.